Impact of genetic variants on the development of obesity and clinical complications
DOI:
https://doi.org/10.70983/pfkhw103Keywords:
Obesity, Inflammation, Genetic variant, Metabolism, CytokinesAbstract
Introduction: Obesity is a multifactorial disease characterized by abnormal growth of adipose tissue and chronic low-grade inflammation state, associated with multiple metabolic alterations. In addition to environmental factors, several single nucleotide variants (SNVs) in genes encoding cytokines, adipokines, and chemokines have been linked to maintenance of the inflammatory state and development of obesity-related clinical complications. Results: Variants in genes such as NLRP3, IL-1β, IL-6, CCL2, TNF-α, and GPX1 have been associated with increased production of pro-inflammatory cytokines and oxidative stress, promoting insulin resistance, and increasing the risk of obesity. Likewise, genetic variants in ACTN3, ADIPOQ, LEPR, and IRS1 influence the regulation of lipid and glucose metabolism, increasing the risk to dyslipidemia, adiposity, cardiovascular disease, and metabolic syndrome. These findings support a comprehensive clinical approach that considers genetics, inflammation, and adipose tissue function for the management of obesity. Conclusion: Obesity remains one of the major public health challenges worldwide, recognized as a complex disease influenced by genetic, metabolic, environmental, and psychological factors. A multidisciplinary approach and the study of genetic variants enable the identification of predisposition markers that support the development of personalized prevention and treatment strategies. However, healthcare is a personal and collective responsibility that involves adopting healthy lifestyle habits and promoting comprehensive care for physical and mental well-being to prevent and avoid the development of this disease.
References
Ahmed, B., Sultana, R., & Greene, M. W. (2021). Adipose tissue and insulin resistance in obese. Biomedicine & Pharmacotherapy, 137, 111315. https://doi.org/10.1016/j.biopha.2021.111315
Arif Ahmad, A., Rahimi, Z., Asadi, S., Vaisi-Raygani, A., & Kohsari, M. (2023). The GPx-1 Gene Variants (rs1050450) in Obesity: Association with the Risk of Obesity and the GPx Activity in Females. Reports of Biochemistry and Molecular Biology, 12(1), 185-194. https://doi.org/10.61186/rbmb.12.1.185
Bairqdar, A., Ivanoshchuk, D., & Shakhtshneider, E. (2023). Functionally Significant Variants in Genes Associated with Abdominal Obesity: A Review. Journal of Personalized Medicine, 13(3), 460. https://doi.org/10.3390/jpm13030460
Barrón‐Cabrera, E., Torres‐Castillo, N., González‐Becerra, K., Zepeda‐Carrillo, E. A., Torres‐Valadez, R., Hernández‐Cañaveral, I., & Martínez‐López, E. (2022). The ACTN3 R577X polymorphism is associated with metabolic alterations in a sex‐dependent manner in subjects from western Mexico. Journal of Human Nutrition and Dietetics, 35(4), 713-721. https://doi.org/10.1111/jhn.12948
Bojarczuk, A., Garbacz, A., Żekanowski, C., Borzemska, B., Cięszczyk, P., & Maculewicz, E. (2024). Systematic Review of IL-1, IL-4, IL-6, IL-10, IL-15, and IL-18 Gene Polymorphisms and Meta-Analysis of IL-6 Variant and Its Association with Overweight and Obesity Risk in Men. International Journal of Molecular Sciences, 25(24), 13501. https://doi.org/10.3390/ijms252413501
Brunner, K. T., Henneberg, C. J., Wilechansky, R. M., & Long, M. T. (2019). Nonalcoholic Fatty Liver Disease and Obesity Treatment. Current Obesity Reports, 8(3), 220-228. https://doi.org/10.1007/s13679-019-00345-1
Caballero, B. (2019). Humans against Obesity: Who Will Win? Advances in Nutrition, 10, S4-S9. https://doi.org/10.1093/advances/nmy055
Chang, W.-W., Zhang, L., Wen, L.-Y., Tao, Y.-J., Xiong, J.-J., Tong, X., Jin, Y.-L., & Su, H. (2023). Association between the MCP-1 -2518 A > G (rs1024611) polymorphism and susceptibility to type 2 diabetes mellitus and diabetic nephropathy: A meta-analysis. BMC Endocrine Disorders, 23(1), 267. https://doi.org/10.1186/s12902-023-01514-z
Chen, Y., Ye, X., Escames, G., Lei, W., Zhang, X., Li, M., Jing, T., Yao, Y., Qiu, Z., Wang, Z., Acuña-Castroviejo, D., & Yang, Y. (2023). The NLRP3 inflammasome: Contributions to inflammation-related diseases. Cellular & Molecular Biology Letters, 28(1), 51. https://doi.org/10.1186/s11658-023-00462-9
Costa Pereira, C., Durães, C., Coelho, R., Grácio, D., Silva, M., Peixoto, A., Lago, P., Pereira, M., Catarino, T., Pinho, S., Teixeira, J. P., Macedo, G., Annese, V., & Magro, F. (2017). Association between Polymorphisms in Antioxidant Genes and Inflammatory Bowel Disease. PLOS ONE, 12(1), e0169102. https://doi.org/10.1371/journal.pone.0169102
de Luis, D. A., Primo, D., Izaola, O., & Aller, R. (2020). Adiponectin Gene Variant rs266729 Interacts with Different Macronutrient Distribution of Two Different Hypocaloric Diets. Lifestyle Genomics, 13(1), 20-27. https://doi.org/10.1159/000503863
Deschamps, C. L., Connors, K. E., Klein, M. S., Johnsen, V. L., Shearer, J., Vogel, H. J., Devaney, J. M., Gordish-Dressman, H., Many, G. M., Barfield, W., Hoffman, E. P., Kraus, W. E., & Hittel, D. S. (2015). The ACTN3 R577X Polymorphism Is Associated with Cardiometabolic Fitness in Healthy Young Adults. PLOS ONE, 10(6), e0130644. https://doi.org/10.1371/journal.pone.0130644
Franzago, M., Di Nicola, M., Fraticelli, F., Marchioni, M., Stuppia, L., & Vitacolonna, E. (2022). Nutrigenetic variants and response to diet/lifestyle intervention in obese subjects: A pilot study. Acta Diabetologica, 59(1), 69-81. https://doi.org/10.1007/s00592-021-01787-7
Freitas, R. de S., de Souza Silva, C. M., Ferreira Fratelli, C., Ramos de Lima, L., Morato Stival, M., Schwerz Funghetto, S., Rodrigues da Silva, I. C., & Vieira de Andrade, R. (2024). IL-10 and IL-1β Serum Levels, Genetic Variants, and Metabolic Syndrome: Insights into Older Adults’ Clinical Characteristics. Nutrients, 16(8), 1241. https://doi.org/10.3390/nu16081241
Gajewska, J., Kuryłowicz, A., Ambroszkiewicz, J., Mierzejewska, E., Chełchowska, M., Szamotulska, K., Weker, H., & Puzianowska‐Kuźnicka, M. (2016). ADIPOQ −11377C>G Polymorphism Increases the Risk of Adipokine Abnormalities and Child Obesity Regardless of Dietary Intake. Journal of Pediatric Gastroenterology and Nutrition, 62(1), 122-129. https://doi.org/10.1097/MPG.0000000000000900
Garcia Robles, M. J., Camarillo Alba, J., Valenzuela Gurrola, M. D. J., López, J. A., & Ramírez-De Los Santos, S. (2020). ADIPQ gene polymorphism rs266729 (-11377 C>G) and metabolic syndrome risk in a Mexican population of western Mexico. Nutrición Hospitalaria. https://doi.org/10.20960/nh.03204
Ghadge, A. A., & Khaire, A. A. (2019). Leptin as a predictive marker for metabolic syndrome. Cytokine, 121, 154735. https://doi.org/10.1016/j.cyto.2019.154735
Ghareeb, D., Abdelazem, A. S., Hussein, E. M., & Al-Karamany, A. S. (2021). Association of TNF-α-308 G>A (rs1800629) polymorphism with susceptibility of metabolic syndrome. Journal of Diabetes and Metabolic Disorders, 20(1), 209-215. https://doi.org/10.1007/s40200-021-00732-3
Gholami, M., Sharifi, F., Shahriari, S., Khoshnevisan, K., Larijani, B., & Amoli, M. M. (2019). Association of interleukin-6 polymorphisms with obesity: A systematic review and meta-analysis. Cytokine, 123, 154769. https://doi.org/10.1016/j.cyto.2019.154769
Harvey, I., Boudreau, A., & Stephens, J. M. (2020). Adipose tissue in health and disease. Open Biology, 10(12), 200291. https://doi.org/10.1098/rsob.200291
Heianza, Y., & Qi, L. (2017). Gene-Diet Interaction and Precision Nutrition in Obesity. International Journal of Molecular Sciences, 18(4), 787. https://doi.org/10.3390/ijms18040787
Hernández Guerrero, C. (2015). EL POLIMORFISMO DE LA GLUTATIÓN PEROXIDASA-1 PRO200LEU (RS1050450) SE. NUTRICION HOSPITALARIA, 4, 1516-1525. https://doi.org/10.3305/nh.2015.32.4.9500
Koc, G., Doran, T., Uygur, M. M., & Kirac, D. (2023). Obesity is associated with IL-6 gene polymorphisms rs1800795 and rs1800796 but not SOCS3 rs4969170. Molecular Biology Reports, 50(3), 2041-2048. https://doi.org/10.1007/s11033-022-08129-y
Kouyama, K., Miyake, K., Zenibayashi, M., Hirota, Y., Teranishi, T., Tamori, Y., Kanda, H., Sakaguchi, K., Ohara, T., & Kasuga, M. (2008). Association of serum MCP-1 concentration and MCP-1 polymorphism with insulin resistance in Japanese individuals with obese type 2 diabetes. The Kobe Journal of Medical Sciences, 53(6), 345-354.
Leońska-Duniec, A., Ficek, K., Świtała, K., & Cięszczyk, P. (2019). Association of the TNF-α -308G/A polymorphism with lipid profile changes in response to aerobic training program. Biology of Sport, 36(3), 291-296. https://doi.org/10.5114/biolsport.2019.85456
Lim, U., Ernst, T., Wilkens, L. R., Albright, C. L., Lum-Jones, A., Seifried, A., Buchthal, S. D., Novotny, R., Kolonel, L. N., Chang, L., Cheng, I., & Le Marchand, L. (2012). Susceptibility Variants for Waist Size in Relation to Abdominal, Visceral, and Hepatic Adiposity in Postmenopausal Women. Journal of the Academy of Nutrition and Dietetics, 112(7), 1048-1055. https://doi.org/10.1016/j.jand.2012.03.034
Lin, X., & Li, H. (2021). Obesity: Epidemiology, Pathophysiology, and Therapeutics. Frontiers in Endocrinology, 12, 706978. https://doi.org/10.3389/fendo.2021.706978
Litwin, M., & Kułaga, Z. (2021). Obesity, metabolic syndrome, and primary hypertension. Pediatric Nephrology, 36(4), 825-837. https://doi.org/10.1007/s00467-020-04579-3
Liu, Y., Chen, Y., Lin, Y., Wei, B., & Luo, Z. (2024). Impacts of pro-inflammatory cytokines variant on cardiometabolic profile and premature coronary artery disease: A systematic review and meta-analysis. Journal of Cellular and Molecular Medicine, 28(8), e18311. https://doi.org/10.1111/jcmm.18311
López-Reyes, A., Martinez-Armenta, C., Espinosa-Velázquez, R., Vázquez-Cárdenas, P., Cruz-Ramos, M., Palacios-Gonzalez, B., Gomez-Quiroz, L. E., & Martínez-Nava, G. A. (2020). NLRP3 Inflammasome: The Stormy Link Between Obesity and COVID-19. Frontiers in Immunology, 11, 570251. https://doi.org/10.3389/fimmu.2020.570251
Ogundele, O. E., Adekoya, K. O., Osinubi, A. A. A., Awofala, A. A., & Oboh, B. O. (2018). Association of adiponectin gene ( ADIPOQ ) polymorphisms with measures of obesity in Nigerian young adults. Egyptian Journal of Medical Human Genetics, 19(2), 123-127. https://doi.org/10.1016/j.ejmhg.2017.08.005
Park, S., Lee, D.-H., Lee, S., & Jeon, H. J. (2024). Association of Monocyte Chemoattractant Protein-1 (MCP-1) 2518 A/G Polymorphism with Obesity in Korean Type 2 Diabetes Mellitus. Diabetes, Metabolic Syndrome and Obesity, 17, 3917-3924. https://doi.org/10.2147/DMSO.S484860
Posadas-Sánchez, R., López-Uribe, Á. R., Fragoso, J. M., & Vargas-Alarcón, G. (2024). Interleukin 6 polymorphisms are associated with cardiovascular risk factors in premature coronary artery disease patients and healthy controls of the GEA Mexican study. Experimental and Molecular Pathology, 136, 104886. https://doi.org/10.1016/j.yexmp.2024.104886
Qi, Q., Bray, G. A., Smith, S. R., Hu, F. B., Sacks, F. M., & Qi, L. (2011). Insulin Receptor Substrate 1 Gene Variation Modifies Insulin Resistance Response to Weight-Loss Diets in a 2-Year Randomized Trial: The Preventing Overweight Using Novel Dietary Strategies (POUNDS LOST) Trial. Circulation, 124(5), 563-571. https://doi.org/10.1161/CIRCULATIONAHA.111.025767
Rubino, F., Cummings, D. E., Eckel, R. H., Cohen, R. V., Wilding, J. P. H., Brown, W. A., Stanford, F. C., Batterham, R. L., Farooqi, I. S., Farpour-Lambert, N. J., Le Roux, C. W., Sattar, N., Baur, L. A., Morrison, K. M., Misra, A., Kadowaki, T., Tham, K. W., Sumithran, P., Garvey, W. T., … Mingrone, G. (2025). Definition and diagnostic criteria of clinical obesity. The Lancet Diabetes & Endocrinology, 13(3), 221-262. https://doi.org/10.1016/S2213-8587(24)00316-4
Singh, R. K., Kumar, P., & Mahalingam, K. (2017). Molecular genetics of human obesity: A comprehensive review. Comptes Rendus. Biologies, 340(2), 87-108. https://doi.org/10.1016/j.crvi.2016.11.007
Stefan, N., Häring, H.-U., Hu, F. B., & Schulze, M. B. (2013). Metabolically healthy obesity: Epidemiology, mechanisms, and clinical implications. The Lancet Diabetes & Endocrinology, 1(2), 152-162. https://doi.org/10.1016/S2213-8587(13)70062-7
Suzuki, K., Inoue, T., Yanagisawa, A., Kimura, A., Ito, Y., & Hamajima, N. (2009). Association between Interleukin-1B C-31T Polymorphism and Obesity in Japanese. Journal of Epidemiology, 19(3), 131-135. https://doi.org/10.2188/jea.JE20081015
Toma, F. M., Kalam, K. T., Haque, Md. A., Reza, S., Akter, R., Islam, M. S., Islam, Md. R., & Nahar, Z. (2025). Interleukin-1β rs16944 and rs1143627 polymorphisms and risk of developing major depressive disorder: A case-control study among Bangladeshi population. PLOS ONE, 20(1), e0317665. https://doi.org/10.1371/journal.pone.0317665
Wu, H., & Ballantyne, C. M. (2020). Metabolic Inflammation and Insulin Resistance in Obesity. Circulation Research, 126(11), 1549-1564. https://doi.org/10.1161/CIRCRESAHA.119.315896
Yang, Y.-H., Liu, Y.-Q., Zhang, L., Li, H., Li, X.-B., Ouyang, Q., & Zhu, G.-Y. (2015). Genetic polymorphisms of the TNF-α-308G/A are associated with metabolic syndrome in asthmatic patients from Hebei province, China. International Journal of Clinical and Experimental Pathology, 8(10), 13739-13746.
Zhang, T., Chen, J., Tang, X., Luo, Q., Xu, D., & Yu, B. (2019). Interaction between adipocytes and high-density lipoprotein:new insights into the mechanism of obesity-induced dyslipidemia and atherosclerosis. Lipids in Health and Disease, 18(1), 223. https://doi.org/10.1186/s12944-019-1170-9
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Autor
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
